The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
The third round of expensive prescription drugs selected for Medicare negotiation were announced this week, covering medications that account for $27 billion in Medicare spending.
News Jan 23, 2026The House passed a government spending bill on Thursday that includes key drug price reforms that P4AD has consistently pushed for since 2023.
News Jan 22, 2026Today, the House passed a government spending bill that included bipartisan prescription drug pricing reforms long supported by Patients For Affordable Drugs Now and our patient advocates.
News Jan 16, 2026Yesterday, the White House released a new healthcare framework – as Americans face the final days of ACA open enrollment and rising health care costs – that raised more questions than it answered.
News Jan 9, 2026P4AD’s founder, David Mitchell, passed away on Friday, January 2nd, after a 15-year battle with multiple myeloma, a rare blood cancer.
News Jan 5, 2026Today, we honor the life, legacy, and friendship of David Mitchell – a tireless public health leader and the founder of Patients For Affordable Drugs – who died on Friday, January 2, 2026.
News Dec 19, 2025This afternoon, the White House announced it has reached agreements with nine more pharmaceutical giants to lower the prices of certain prescription drugs for patients who purchase them directly…
News Dec 12, 2025More most-favored-nation (MFN) drug pricing deals are expected this month, according to CMS Administrator Dr. Oz.
News Dec 5, 2025Last Tuesday, the Centers for Medicare and Medicaid Services (CMS) announced new lower prices for the second round of Medicare drug price negotiations.
News Nov 25, 2025Patients on Medicare will see an average list price reduction of 62% percent on the 15 included drugs.
